| 1 |
Xie Y, Xu J, Zhou D, Guo M, Zhang M, Gao Y, Liu M, Shi J, Yang K, Zheng Q, Zhao L, Qin Y, Hu R, Wei J, Zhang J, Tian J. Micronutrient perspective on COVID-19: Umbrella review and reanalysis of meta-analyses. Crit Rev Food Sci Nutr 2023;:1-19. [PMID: 36794398 DOI: 10.1080/10408398.2023.2174948] [Reference Citation Analysis]
|
| 2 |
Siemens W, Nothacker J, Stadelmaier J, Meerpohl JJ, Schmucker C. Three out of four published systematic reviews on COVID-19 treatments were not registered and one-third of those registered were published: a meta-research study. J Clin Epidemiol 2022;152:36-46. [PMID: 36179937 DOI: 10.1016/j.jclinepi.2022.09.011] [Reference Citation Analysis]
|
| 3 |
Gibbons JB, Norton EC, McCullough JS, Meltzer DO, Lavigne J, Fiedler VC, Gibbons RD. Association between vitamin D supplementation and COVID-19 infection and mortality. Sci Rep 2022;12:19397. [PMID: 36371591 DOI: 10.1038/s41598-022-24053-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Said SA, Abdulbaset A, El-kholy AA, Besckales O, Sabri NA. The effect of Nigella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1011522] [Reference Citation Analysis]
|
| 5 |
Feiner Solís Á, Avedillo Salas A, Luesma Bartolomé MJ, Santander Ballestín S. The Effects of Vitamin D Supplementation in COVID-19 Patients: A Systematic Review. IJMS 2022;23:12424. [DOI: 10.3390/ijms232012424] [Reference Citation Analysis]
|
| 6 |
Marjot T, Eberhardt CS, Boettler T, Belli LS, Berenguer M, Buti M, Jalan R, Mondelli MU, Moreau R, Shouval D, Berg T, Cornberg M. Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper. J Hepatol 2022;77:1161-97. [PMID: 35868584 DOI: 10.1016/j.jhep.2022.07.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 7 |
Sinopoli A, Caminada S, Isonne C, Santoro MM, Baccolini V. What Are the Effects of Vitamin A Oral Supplementation in the Prevention and Management of Viral Infections? A Systematic Review of Randomized Clinical Trials. Nutrients 2022;14:4081. [PMID: 36235733 DOI: 10.3390/nu14194081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Nyirenda JL, Sofroniou M, Toews I, Mikolajewska A, Lehane C, Monsef I, Abu-Taha A, Maun A, Stegemann M, Schmucker C. Fluvoxamine for the treatment of COVID-19. Cochrane Database Syst Rev 2022;9:CD015391. [PMID: 36103313 DOI: 10.1002/14651858.CD015391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Schrimpf A, Braesigk A, Lippmann S, Bleckwenn M. Management and treatment of long COVID symptoms in general practices: An online-based survey. Front Public Health 2022;10:937100. [PMID: 36176520 DOI: 10.3389/fpubh.2022.937100] [Reference Citation Analysis]
|
| 10 |
Menger J, Lee Z, Notz Q, Wallqvist J, Hasan MS, Elke G, Dworschak M, Meybohm P, Heyland DK, Stoppe C. Administration of vitamin D and its metabolites in critically ill adult patients: an updated systematic review with meta-analysis of randomized controlled trials. Crit Care 2022;26:268. [DOI: 10.1186/s13054-022-04139-1] [Reference Citation Analysis]
|
| 11 |
Chen Z, Luo J, Li S, Xu P, Zeng L, Yu Q, Zhang L. Characteristics of Living Systematic Review for COVID-19. CLEP 2022;Volume 14:925-35. [DOI: 10.2147/clep.s367339] [Reference Citation Analysis]
|
| 12 |
Povaliaeva A, Bogdanov V, Pigarova E, Dzeranova L, Katamadze N, Malysheva N, Ioutsi V, Nikankina L, Rozhinskaya L, Mokrysheva N. Impaired Vitamin D Metabolism in Hospitalized COVID-19 Patients. Pharmaceuticals (Basel) 2022;15. [PMID: 35893730 DOI: 10.3390/ph15080906] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 13 |
Passini CSM, Cavalcanti MB, Ribas SA, de Carvalho CMP, Bocca C, Lamarca F. Conflict of Interests in the Scientific Production on Vitamin D and COVID-19: A Scoping Review. Front Public Health 2022;10:821740. [DOI: 10.3389/fpubh.2022.821740] [Reference Citation Analysis]
|
| 14 |
Briceno Noriega D, Savelkoul HFJ. Vitamin D: A Potential Mitigation Tool for the Endemic Stage of the COVID-19 Pandemic? Front Public Health 2022;10:888168. [PMID: 35757617 DOI: 10.3389/fpubh.2022.888168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Tricarico G, Travagli V. Approach to the management of COVID-19 patients: When home care can represent the best practice. Int J Risk Saf Med 2022. [PMID: 35786662 DOI: 10.3233/JRS-210064] [Reference Citation Analysis]
|
| 16 |
Popp M, Reis S, Schießer S, Hausinger RI, Stegemann M, Metzendorf MI, Kranke P, Meybohm P, Skoetz N, Weibel S. Ivermectin for preventing and treating COVID-19. Cochrane Database Syst Rev 2022;6:CD015017. [PMID: 35726131 DOI: 10.1002/14651858.CD015017.pub3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 17 |
Chiang W, Hsiao P, Chan J. Vitamin D for Recovery of COVID-19 in Patients With Chronic Kidney Disease. Front Nutr 2022;9:930176. [DOI: 10.3389/fnut.2022.930176] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 18 |
Kramer A, Prinz C, Fichtner F, Fischer AL, Thieme V, Grundeis F, Spagl M, Seeber C, Piechotta V, Metzendorf MI, Golinski M, Moerer O, Stephani C, Mikolajewska A, Kluge S, Stegemann M, Laudi S, Skoetz N. Janus kinase inhibitors for the treatment of COVID-19. Cochrane Database Syst Rev 2022;6:CD015209. [PMID: 35695334 DOI: 10.1002/14651858.CD015209] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 19 |
Mariani J, Antonietti L, Tajer C, Ferder L, Inserra F, Sanchez Cunto M, Brosio D, Ross F, Zylberman M, López DE, Luna Hisano C, Maristany Batisda S, Pace G, Salvatore A, Hogrefe JF, Turela M, Gaido A, Rodera B, Banega E, Iglesias ME, Rzepeski M, Gomez Portillo JM, Bertelli M, Vilela A, Heffner L, Annetta VL, Moracho L, Carmona M, Melito G, Martínez MJ, Luna G, Vensentini N, Manucha W. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: Multicentre randomized controlled clinical trial. PLoS One 2022;17:e0267918. [PMID: 35622854 DOI: 10.1371/journal.pone.0267918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Parthymou A, Habeos EE, Habeos GI, Deligakis A, Livieratos E, Marangos M, Chartoumpekis DV. Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece. BMJ Open 2022;12:e057084. [PMID: 35589363 DOI: 10.1136/bmjopen-2021-057084] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 21 |
Kaduszkiewicz H, Kochen MM, Kluge S, Malin JJ, Weibel S, Skoetz N. Recommendations for the outpatient drug treatment of patients with COVID-19. Deutsches Ärzteblatt international 2022. [DOI: 10.3238/arztebl.m2022.0203] [Reference Citation Analysis]
|
| 22 |
Kazemi E, Mansoursamaei A, Rohani-Rasaf M, Sheibani H. Comparison of the cardiovascular system, clinical condition, and laboratory results in COVID-19 patients with and without vitamin D insufficiency. BMC Infect Dis 2022;22:441. [PMID: 35525957 DOI: 10.1186/s12879-022-07438-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Karampela Ι, Vallianou N, Magkos F, Apovian CM, Dalamaga Μ. Obesity, Hypovitaminosis D, and COVID-19: the Bermuda Triangle in Public Health. Curr Obes Rep 2022. [PMID: 35391661 DOI: 10.1007/s13679-022-00471-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 24 |
Pludowski P, Takacs I, Boyanov M, Belaya Z, Diaconu CC, Mokhort T, Zherdova N, Rasa I, Payer J, Pilz S. Clinical Practice in the Prevention, Diagnosis and Treatment of Vitamin D Deficiency: A Central and Eastern European Expert Consensus Statement. Nutrients 2022;14:1483. [DOI: 10.3390/nu14071483] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 25 |
García-Lledó A, Gómez-Pavón J, González Del Castillo J, Hernández-Sampelayo T, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, García-Botella A, Bouza E. Pharmacological treatment of COVID-19: an opinion paper. Rev Esp Quimioter 2022;35:115-30. [PMID: 34894208 DOI: 10.37201/req/158.2021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 26 |
Stoia M, Oancea S. Low-Molecular-Weight Synthetic Antioxidants: Classification, Pharmacological Profile, Effectiveness and Trends. Antioxidants 2022;11:638. [DOI: 10.3390/antiox11040638] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 27 |
Bania A, Pitsikakis K, Mavrovounis G, Mermiri M, Beltsios ET, Adamou A, Konstantaki V, Makris D, Tsolaki V, Gourgoulianis K, Pantazopoulos I. Therapeutic Vitamin D Supplementation Following COVID-19 Diagnosis: Where Do We Stand?—A Systematic Review. JPM 2022;12:419. [DOI: 10.3390/jpm12030419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 28 |
Tylicki P, Polewska K, Och A, Susmarska A, Puchalska-Reglińska E, Parczewska A, Biedunkiewicz B, Szabat K, Renke M, Tylicki L, Dębska-Ślizień A. Angiotensin Converting Enzyme Inhibitors May Increase While Active Vitamin D May Decrease the Risk of Severe Pneumonia in SARS-CoV-2 Infected Patients with Chronic Kidney Disease on Maintenance Hemodialysis. Viruses 2022;14:451. [PMID: 35336859 DOI: 10.3390/v14030451] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 29 |
Tang JW, Caniza MA, Dinn M, Dwyer DE, Heraud J, Jennings LC, Kok J, Kwok KO, Li Y, Loh TP, Marr LC, Nara EM, Perera N, Saito R, Santillan-salas C, Sullivan S, Warner M, Watanabe A, Zaidi SK. An exploration of the political, social, economic and cultural factors affecting how different global regions initially reacted to the COVID-19 pandemic. Interface Focus 2022;12:20210079. [DOI: 10.1098/rsfs.2021.0079] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 30 |
Regalia A, Benedetti M, Malvica S, Alfieri C, Campise M, Cresseri D, Gandolfo MT, Tripodi F, Castellano G, Messa P. Vitamin D Status and SARS-CoV-2 Infection in a Cohort of Kidney Transplanted Patients. Nutrients 2022;14:317. [PMID: 35057498 DOI: 10.3390/nu14020317] [Reference Citation Analysis]
|
| 31 |
Pilz S, Trummer C, Theiler-Schwetz V, Grübler MR, Verheyen ND, Odler B, Karras SN, Zittermann A, März W. Critical Appraisal of Large Vitamin D Randomized Controlled Trials. Nutrients 2022;14:303. [PMID: 35057483 DOI: 10.3390/nu14020303] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 32 |
Israel A, Cicurel A, Feldhamer I, Stern F, Dror Y, Giveon SM, Gillis D, Strich D, Lavie G. Vitamin D deficiency is associated with higher risks for SARS-CoV-2 infection and COVID-19 severity: a retrospective case-control study. Intern Emerg Med 2022. [PMID: 35000118 DOI: 10.1007/s11739-021-02902-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 33 |
Tylicki L, Puchalska-Reglińska E, Tylicki P, Och A, Polewska K, Biedunkiewicz B, Parczewska A, Szabat K, Wolf J, Dębska-Ślizień A. Predictors of Mortality in Hemodialyzed Patients after SARS-CoV-2 Infection. J Clin Med 2022;11:285. [PMID: 35053983 DOI: 10.3390/jcm11020285] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 34 |
Quinn EK, Fenton S, Ford-Sahibzada CA, Harper A, Marcon AR, Caulfield T, Fazel SS, Peters CE. COVID-19 and Vitamin D Misinformation on YouTube: Content Analysis. JMIR Infodemiology 2022;2:e32452. [PMID: 35310014 DOI: 10.2196/32452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Gayan-Ramirez G, Janssens W. Vitamin D Actions: The Lung Is a Major Target for Vitamin D, FGF23, and Klotho. JBMR Plus 2021;5:e10569. [PMID: 34950829 DOI: 10.1002/jbm4.10569] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 36 |
Crisafulli S, Ientile V, L'Abbate L, Fontana A, Linguiti C, Manna S, Mercaldo M, Pagliaro C, Vezzaro M, Santacà K, Lora R, Moretti U, Reno C, Fantini MP, Corrao S, Barbato D, Tari M, Trifirò G, The Ita-Covid Cov-Out Group. COVID-19 Patient Management in Outpatient Setting: A Population-Based Study from Southern Italy. J Clin Med 2021;11:51. [PMID: 35011810 DOI: 10.3390/jcm11010051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 37 |
Eisele-Metzger A, Bollig C, Meerpohl JJ. Systematic reviews should be at the heart of continuing medical education. J Eur CME 2021;10:2014096. [PMID: 34925964 DOI: 10.1080/21614083.2021.2014096] [Reference Citation Analysis]
|
| 38 |
Loucera C, Peña-Chilet M, Esteban-Medina M, Muñoyerro-Muñiz D, Villegas R, Lopez-Miranda J, Rodriguez-Baño J, Túnez I, Bouillon R, Dopazo J, Quesada Gomez JM. Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients. Sci Rep 2021;11:23380. [PMID: 34862422 DOI: 10.1038/s41598-021-02701-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 39 |
Murai IH, Fernandes AL, Antonangelo L, Gualano B, Pereira RMR. Effect of a Single High-Dose Vitamin D3 on the Length of Hospital Stay of Severely 25-Hydroxyvitamin D-Deficient Patients with COVID-19. Clinics (Sao Paulo) 2021;76:e3549. [PMID: 34852148 DOI: 10.6061/clinics/2021/e3549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 40 |
El Zakhem A, Chalhoub MA, Bassil M. The Role of Herbal and Nutritional Treatments in the Fight against COVID-19 and Other Respiratory Tract Infections. Int J Environ Res Public Health 2021;18:12001. [PMID: 34831757 DOI: 10.3390/ijerph182212001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 41 |
Popp M, Stegemann M, Riemer M, Metzendorf MI, Romero CS, Mikolajewska A, Kranke P, Meybohm P, Skoetz N, Weibel S. Antibiotics for the treatment of COVID-19. Cochrane Database Syst Rev 2021;10:CD015025. [PMID: 34679203 DOI: 10.1002/14651858.CD015025] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 42 |
Kongsbak-Wismann M, Al-Jaberi FAH, Schmidt JD, Ghanizada M, Hansen CB, Lopez DV, Woetmann A, Ødum N, Bonefeld CM, Stryhn A, Garred P, Buus S, Geisler C. Normal T and B Cell Responses Against SARS-CoV-2 in a Family With a Non-Functional Vitamin D Receptor: A Case Report. Front Immunol 2021;12:758154. [PMID: 34659264 DOI: 10.3389/fimmu.2021.758154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
Arroyo-Díaz JA, Julve J, Vlacho B, Corcoy R, Ponte P, Román E, Navas-Méndez E, Llauradó G, Franch-Nadal J, Domingo P, Mauricio D. Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study. Front Public Health 2021;9:758347. [PMID: 34631653 DOI: 10.3389/fpubh.2021.758347] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 44 |
Ghelani D, Alesi S, Mousa A. Vitamin D and COVID-19: An Overview of Recent Evidence. Int J Mol Sci 2021;22:10559. [PMID: 34638897 DOI: 10.3390/ijms221910559] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 45 |
Ben-Eltriki M, Hopefl R, Wright JM, Deb S. Association between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational Studies. J Am Coll Nutr 2021;:1-11. [PMID: 34464543 DOI: 10.1080/07315724.2021.1951891] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 46 |
Quinn EK, Fenton S, Ford-sahibzada CA, Harper A, Marcon AR, Caulfield T, Fazel SS, Peters CE. COVID-19 and Vitamin D Misinformation on YouTube: Content Analysis (Preprint).. [DOI: 10.2196/preprints.32452] [Reference Citation Analysis]
|
| 47 |
Wieland LS. Vitamin D supplementation for the treatment of COVID-19: Summary of a living Cochrane review. Explore (NY) 2021;17:481-2. [PMID: 34294560 DOI: 10.1016/j.explore.2021.06.004] [Reference Citation Analysis]
|
| 48 |
Townsend L, Dyer AH, McCluskey P, O'Brien K, Dowds J, Laird E, Bannan C, Bourke NM, Ní Cheallaigh C, Byrne DG, Kenny RA. Investigating the Relationship between Vitamin D and Persistent Symptoms Following SARS-CoV-2 Infection. Nutrients 2021;13:2430. [PMID: 34371940 DOI: 10.3390/nu13072430] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 49 |
Tort S, Burch J. For people with moderate to severe COVID-19, what are the benefits and harms of vitamin D supplementation? Cochrane Clinical Answers 2021. [DOI: 10.1002/cca.3689] [Reference Citation Analysis]
|
| 50 |
Stroehlein JK, Wallqvist J, Iannizzi C, Mikolajewska A, Metzendorf MI, Benstoem C, Meybohm P, Becker M, Skoetz N, Stegemann M, Piechotta V. Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Cochrane Database Syst Rev 2021;5:CD015043. [PMID: 34029377 DOI: 10.1002/14651858.CD015043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 48] [Article Influence: 2.5] [Reference Citation Analysis]
|
